Most adults leave their annual physical with a printout of lab values they don’t fully understand. Blood pressure: 128/82. LDL: 118. Glucose: 97. The nurse says everything looks “okay” or “a little high,” and the appointment ends. These numbers are filed in a portal and largely forgotten until next year — when a slightly different set will be met with the same vague reassurance.
This is an enormous missed opportunity. Each of these numbers reflects a specific physiological process happening in your cardiovascular system right now. Understanding what they measure, what the targets mean, and what happens when they’re off gives you the ability to participate meaningfully in your own cardiovascular health management.
1. Blood Pressure — The Number Most Adults Have But Many Don’t Understand
Blood pressure consists of two values: systolic pressure (the top number) — the pressure in your arteries when the heart contracts and forces blood out — and diastolic pressure (the bottom number) — the pressure when the heart is relaxed and filling between beats.
- Normal: Less than 120/80 mmHg
- Elevated: Systolic 120–129, diastolic less than 80
- Hypertension Stage 1: 130–139/80–89
- Hypertension Stage 2: 140/90 or higher
- Hypertensive crisis: Above 180/120 (requires immediate evaluation)
The 2017 ACC/AHA guideline update lowered the diagnostic threshold from the previous 140/90 — a change motivated by evidence that cardiovascular risk begins rising above 115/75 and accelerates through the 120s and 130s. Many patients who were “fine” under the old threshold are now in the elevated or Stage 1 range, which represents an opportunity for early lifestyle intervention before more significant treatment is required.
Why single clinic readings mislead: Blood pressure varies throughout the day, rises with stress, and is affected by the clinical environment itself. White coat hypertension — blood pressure that is elevated in a clinic setting but normal during daily life — affects 15 to 30 percent of patients diagnosed with hypertension clinically. Masked hypertension — normal clinic readings but elevated daily readings — is potentially more dangerous because it goes undetected. Home blood pressure monitoring with a validated upper-arm device, two readings taken one minute apart in the morning before medication and food, provides far more reliable information.
2. LDL Cholesterol — The Primary Driver of Artery Disease
LDL (low-density lipoprotein) cholesterol is the primary driver of atherosclerosis — the buildup of plaque in arterial walls that underlies coronary artery disease, stroke, and peripheral artery disease. LDL particles penetrate arterial walls, become oxidized, trigger an inflammatory response, and become incorporated into plaque that narrows and stiffens arteries over years.
- Optimal: Less than 100 mg/dL
- Near optimal: 100–129 mg/dL
- Borderline high: 130–159 mg/dL
- High: 160–189 mg/dL
- Very high: 190 mg/dL or above
For adults with established cardiovascular disease, guidelines target LDL below 70 mg/dL. For patients at very high risk, the European Society of Cardiology recommends targets below 55 mg/dL. Non-HDL cholesterol — total cholesterol minus HDL — is a better overall predictor of cardiovascular risk in patients with elevated triglycerides or metabolic syndrome. The non-HDL target is typically the LDL target plus 30 mg/dL.
3. HDL Cholesterol — More Complex Than “Good Cholesterol”
HDL (high-density lipoprotein) is involved in reverse cholesterol transport — retrieving cholesterol from peripheral tissues and returning it to the liver. Higher HDL is epidemiologically associated with lower cardiovascular risk.
- Protective: 60 mg/dL or above
- Low (risk factor): Below 40 mg/dL in men, below 50 mg/dL in women
The best lifestyle interventions for raising HDL are regular aerobic exercise, smoking cessation, and modest weight loss. Despite decades of research, medications specifically designed to raise HDL — including niacin and the CETP inhibitors — have not reduced cardiovascular events in clinical trials, even when they successfully raise HDL levels. This has prompted a more nuanced understanding: not all HDL is functionally equivalent, and a higher number does not always translate into better biological activity.
4. Triglycerides — The Overlooked Lipid
Triglycerides are the most common form of fat in the bloodstream, and their levels reflect the balance between dietary fat and carbohydrate intake, liver lipid production, and peripheral fat clearance.
- Normal: Less than 150 mg/dL
- Borderline high: 150–199 mg/dL
- High: 200–499 mg/dL
- Very high: 500 mg/dL or above (pancreatitis risk)
Elevated triglycerides are most commonly driven by excess refined carbohydrate and sugar consumption, alcohol use, insulin resistance, and physical inactivity — the same factors that drive metabolic syndrome. They rarely rise in isolation; elevated triglycerides typically co-occur with low HDL, elevated blood glucose, and elevated blood pressure as part of the metabolic syndrome cluster.
5. Blood Glucose and HbA1c — Your Sugar Numbers
Fasting blood glucose measures glucose concentration after at least 8 hours without eating. HbA1c measures the percentage of hemoglobin molecules with glucose attached, reflecting average blood glucose over the preceding 2 to 3 months.
- Normal: Fasting glucose 70–99 mg/dL; HbA1c below 5.7%
- Prediabetes: Fasting glucose 100–125 mg/dL; HbA1c 5.7–6.4%
- Diabetes: Fasting glucose 126 mg/dL or above (twice); HbA1c 6.5% or above
The prediabetes range deserves emphasis. An estimated 38 percent of US adults have prediabetes — most undiagnosed. The DPP (Diabetes Prevention Program) showed that intensive lifestyle modification (7% weight loss, 150 minutes per week of activity) reduces progression to diabetes by 58 percent — more effective than metformin. Type 2 diabetes increases cardiovascular risk by 2 to 4 fold; newer medications (SGLT2 inhibitors and GLP-1 receptor agonists) reduce cardiovascular events in diabetic patients independently of their glucose-lowering effects.
6. BMI and Waist Circumference — Body Composition Metrics
BMI (normal 18.5–24.9; overweight 25–29.9; obese ≥30) is widely used but has limitations — it cannot distinguish muscle from fat, and risk relationships vary by ethnicity. Waist circumference is more informative for cardiovascular risk because it reflects visceral adiposity — the abdominal fat that is metabolically active and directly drives insulin resistance, dyslipidemia, and inflammation.
- Metabolic risk threshold: Above 40 inches in men, above 35 inches in women
The waist-to-height ratio provides a simple practical proxy: a ratio below 0.5 is associated with substantially lower cardiovascular risk across diverse populations — and the message is easy to remember: keep your waist less than half your height.
7. Resting Heart Rate — Your Heart’s Efficiency at Rest
Resting heart rate (normal 60–100 bpm; optimal 50–70 bpm) is rarely discussed in standard preventive care but is among the most informative and accessible cardiovascular numbers. Each 10 beats per minute increase in resting heart rate is associated with approximately a 20 percent increase in all-cause mortality risk, independent of other cardiovascular risk factors — and this association holds within the “normal” range.
Measure accurately: lie still for five minutes, then count beats for a full 60 seconds before caffeine or activity. Wearable devices provide continuous trending, which is far more informative than single readings. A resting heart rate that has risen 10 bpm over three months without explanation is worth discussing with a physician.
8. Your 10-Year ASCVD Risk Score
The ACC/AHA Pooled Cohort Equations calculate your 10-year risk of heart attack or stroke using: age, sex, race, total cholesterol, HDL, systolic BP, BP treatment status, smoking, and diabetes.
- Low: Less than 5%
- Borderline: 5–7.5%
- Intermediate: 7.5–20%
- High: 20% or above
The 7.5 percent threshold is clinically important: above this level, ACC/AHA guidelines recommend a clinician-patient discussion about initiating statin therapy. Risk-enhancing factors — family history of premature CVD, elevated Lp(a), elevated hs-CRP, elevated coronary artery calcium score, ankle-brachial index below 0.9 — can push borderline or intermediate-risk patients toward higher risk and stronger indications for treatment.
9. Beyond the Basics — Numbers Worth Asking Your Doctor About
Lipoprotein(a) [Lp(a)]: An LDL-like particle that promotes thrombosis and atherosclerosis. Largely genetically determined, does not respond to statins, and affects approximately one in five people globally. Threshold for elevated risk: ≥50 mg/dL (or ≥125 nmol/L). Measured once — it changes minimally over time. Most useful for risk reclassification in borderline-risk patients.
High-sensitivity CRP (hs-CRP): A systemic inflammation marker. Low risk: <1 mg/L; average: 1–3 mg/L; elevated cardiovascular risk: >3 mg/L. Most useful in borderline-risk patients considering statin initiation. Levels above 10 mg/L typically suggest acute infection or inflammation rather than chronic vascular risk.
Coronary Artery Calcium (CAC) score: A low-dose CT scan detecting calcium deposits in coronary arteries. A score of zero significantly reduces calculated near-term cardiovascular risk and can support deferring statin therapy. A high score reclassifies borderline patients to high risk. Most valuable for intermediate-risk patients in whom statin initiation is genuinely uncertain.
eGFR (kidney function): An eGFR below 60 mL/min/1.73m² defines CKD, an independent cardiovascular risk factor. Kidney disease activates the RAAS, promotes vascular calcification, causes anemia, and impairs endothelial function — all worsening cardiovascular outcomes.
How Often to Get These Numbers Checked
- Blood pressure: Every 1–2 years if normal; every 3–6 months if elevated or treated; home monitoring for borderline or elevated readings
- Lipid panel: Starting age 20; every 4–6 years if normal; annually on statin therapy or with elevated risk
- Fasting glucose/HbA1c: Starting age 35 for overweight adults (ADA), earlier with risk factors; every 3 years if normal; annually if prediabetes
- BMI and waist circumference: At every primary care visit
- ASCVD risk score: Every 4–6 years for adults age 40–79; sooner with significant risk factor changes
- Lp(a), hs-CRP, CAC: Once, for borderline-risk patients who need clarification about treatment decisions
To understand what these numbers look like when they’re in the healthy range, see our article on signs of a healthy heart. For a broader view of the factors that drive these numbers in the wrong direction, visit our guide to what affects heart and blood vessel health. And for the foundational context that makes these numbers meaningful, see our overview of what heart health means.
Heart health numbers are physiological signals — measurements of specific biological processes — that together tell a story about how the cardiovascular system is functioning and where it may be heading. According to the American Heart Association, knowing and managing these numbers is one of the most powerful things adults can do for long-term cardiovascular health. The NIH National Heart, Lung, and Blood Institute provides detailed guidance on blood pressure and cholesterol management. The CDC offers resources for understanding and reducing cardiovascular risk through lifestyle and medical management. The numbers are knowable. The targets are achievable. The first step is understanding what you’re looking at.
Interpreting Your Numbers: Context Matters More Than Single Values
A single out-of-range number rarely tells the complete story of your cardiovascular health. Treating every borderline reading as a crisis — or every in-range reading as permission to ignore it — misses the point of what these numbers are designed to do.
Consider blood pressure. A reading of 132/84 at a single clinic visit, taken after a stressful commute, could reflect white coat effect, temporary stress response, or genuinely elevated resting blood pressure. The clinical response should be to repeat it — at home, consistently, over several weeks — not to immediately start antihypertensive medication. Conversely, home readings that consistently average 135/87 over a month are more clinically meaningful than any single “normal” clinic reading.
Consider LDL. A reading of 118 mg/dL in a 35-year-old with no cardiovascular history, normal blood pressure, no diabetes, and a non-smoking status may not require medication — lifestyle modification and monitoring are appropriate. The same LDL of 118 in a 55-year-old with hypertension, prediabetes, a 10-year ASCVD risk of 12%, and a father who had a heart attack at 58 is a very different clinical picture that almost certainly warrants statin therapy. The number is the same; the context changes everything.
This is why the most useful outcome of knowing your heart health numbers is not a pass/fail assessment but a structured conversation with your healthcare provider about what your numbers mean given your specific age, sex, risk factor profile, family history, and lifestyle. That conversation should happen at least every 4 to 6 years for adults with normal numbers and more frequently for adults with borderline or elevated readings.
What the Numbers Look Like When They’re Moving in the Right Direction
For adults actively working to improve their cardiovascular health, knowing what improvement looks like in each number is motivating and instructive.
Blood pressure responds relatively quickly to lifestyle change. Reducing sodium intake by 1,000 mg per day typically reduces systolic blood pressure by 4 to 6 mmHg within 4 to 6 weeks. Regular aerobic exercise (150 minutes per week of moderate intensity) produces reductions of 5 to 8 mmHg systolic in hypertensive patients within 12 weeks. Weight loss of 5 kg produces reductions of approximately 4 to 5 mmHg systolic. These effects are additive — someone who exercises, reduces sodium, and loses weight may reduce systolic blood pressure by 15 to 20 mmHg, enough to bring Stage 1 hypertension back to normal range without medication.
LDL cholesterol responds to dietary change within 4 to 6 weeks. Reducing saturated fat intake from 15% to 7% of total calories typically reduces LDL by 8 to 10 percent. Adding soluble fiber (oat bran, psyllium, legumes) can reduce LDL by a further 5 to 10 percent. Statin therapy produces 30 to 50 percent LDL reduction depending on intensity. The combination of dietary change and statin therapy produces LDL reductions of 40 to 60 percent from baseline — often enough to bring even substantially elevated LDL to target.
Fasting glucose responds directly to aerobic exercise (which improves insulin sensitivity within 24 hours of a single exercise session, with cumulative effects over weeks), dietary change (particularly reducing refined carbohydrates), and weight loss. HbA1c, reflecting three-month average glucose, takes 3 months to fully capture the benefit of lifestyle change — making it the appropriate monitoring frequency when tracking improvement in glucose control.
Resting heart rate declines with progressive aerobic fitness — typically 5 to 10 bpm within the first 8 to 12 weeks of a consistent exercise program, continuing to decline gradually over months and years of sustained training. Watching your resting heart rate trend downward on a wearable device is one of the most concrete pieces of evidence that your cardiovascular system is adapting to exercise in the expected and beneficial way.
Each of these numbers, taken individually, is a data point. Taken together over time, they become a narrative about how your cardiovascular system is functioning, adapting, and aging — or not aging. The goal of tracking them is not anxiety about every fluctuation but informed engagement with a system whose health determines whether every other system in your body can function at its best.
The Role of Medication in Managing These Numbers
For many adults, lifestyle modification alone is sufficient to bring borderline numbers into the healthy range. But for adults whose numbers are substantially elevated, whose absolute cardiovascular risk is high, or whose lifestyle changes have not produced adequate improvement after 3 to 6 months of genuine effort, medication becomes an important and evidence-based part of managing these numbers.
Statins are the cornerstone of LDL management in patients at elevated cardiovascular risk. High-intensity statins (atorvastatin 40–80 mg, rosuvastatin 20–40 mg) reduce LDL by 40 to 50 percent and are the standard of care for patients with established atherosclerotic disease. For patients who cannot tolerate statins or who cannot reach target LDL on statins alone, PCSK9 inhibitors (evolocumab, alirocumab) can reduce LDL by an additional 50 to 60 percent, achieving LDL levels below 30 mg/dL in some patients.
Antihypertensive medications are indicated for most patients with Stage 1 hypertension (130–139/80–89) who have an ASCVD risk of 10 percent or above, and for all patients with Stage 2 hypertension (≥140/90). First-line options include ACE inhibitors or ARBs (particularly appropriate with diabetes or proteinuria), calcium channel blockers (well-tolerated, effective in most patients), and thiazide diuretics (low-cost, evidence-based). Many patients require two or more medications to reach target blood pressure.
Metformin is the first-line pharmacological option for type 2 diabetes management and is increasingly used in prediabetes for patients at high risk of progression. SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) and GLP-1 receptor agonists (semaglutide, liraglutide) have demonstrated cardiovascular outcome benefits in patients with established CVD or high cardiovascular risk, independent of their glucose-lowering effects.
The goal of medication in managing heart health numbers is not to achieve a “normal” number on a lab printout but to reduce long-term cardiovascular risk — specifically, to reduce the probability of a heart attack, stroke, or heart failure event over the next 10 years and beyond. Understanding this distinction changes the relationship patients have with their medications: not as a fix for a number, but as a long-term investment in the cardiovascular system that sustains everything else.
Making These Numbers Part of Your Annual Conversation
The most practical step any adult can take with this information is to prepare for their annual preventive care visit with a specific set of questions and requests. Ask what your ASCVD 10-year risk score is and what it means for your statin decision. Ask what your Lp(a) is if you have a family history of premature heart disease and have never been tested. Ask for a home blood pressure log if your clinic readings have been borderline. Ask what your trend is — how does your cholesterol this year compare to last year, and the year before?
These are not demanding or unusual requests. They are the natural consequence of knowing what heart health numbers mean and understanding that each number connects to a specific physiological process that can be tracked, managed, and improved. The adults who do best over the long term in cardiovascular health are not necessarily the ones who are born with the best numbers — they are the ones who know their numbers, understand them, and act on them consistently over decades.
A Summary of the Key Heart Health Numbers
For quick reference, here is a summary of the core heart health numbers every adult should know, with their optimal targets:
- Blood pressure: Less than 120/80 mmHg; home morning average is more reliable than single clinic readings
- LDL cholesterol: Less than 100 mg/dL (general); less than 70 (high-risk); less than 55 (very high-risk per ESC)
- HDL cholesterol: 60 mg/dL or above protective; below 40 (men) or 50 (women) is a risk factor
- Triglycerides: Less than 150 mg/dL; elevated levels reflect metabolic syndrome, insulin resistance, or dietary excess
- Fasting glucose: 70–99 mg/dL normal; 100–125 = prediabetes (requires action); ≥126 = diabetes
- HbA1c: Below 5.7% normal; 5.7–6.4% = prediabetes; ≥6.5% = diabetes
- Waist circumference: Below 40 inches (men) and 35 inches (women); visceral fat is the relevant metabolic risk factor
- Resting heart rate: 50–70 bpm optimal; each 10 bpm rise is associated with ~20% higher all-cause mortality
- 10-year ASCVD risk: Below 5% = low risk; ≥7.5% = begin discussion about statin therapy; ≥20% = high risk
- Lp(a): Below 50 mg/dL; elevated in ~20% of adults; measure once, particularly with family history of premature CVD
- hs-CRP: Below 1 mg/L = low inflammatory risk; 1–3 = average; above 3 = elevated vascular risk
- eGFR: Above 60 mL/min/1.73m² = normal kidney function; below 60 = CKD and independent cardiovascular risk
None of these numbers tells the whole story in isolation. Together, they provide a comprehensive, actionable picture of cardiovascular health — one that becomes progressively more valuable as it is tracked, understood, and discussed with a healthcare provider over time.